Hematology/Oncology Fellowship Programs' Participation in the Quality Oncology Practice Initiative.

Journal Article (Journal Article)

PURPOSE: In the first decade of this millennium, ASCO pioneered a quality measurement tool, the Quality Oncology Practice Initiative (QOPI). Despite an Accreditation Council for Graduate Medical Education (ACGME) requirement since 2012 for oncology fellows to participate in quality improvement (QI) projects, the uptake of QOPI remains modest. METHODS: This study examined reasons for low QOPI participation by surveying participating and nonparticipating HemOnc Fellowship Programs. The survey elicited views toward QI and QOPI as well as ideas about making the program more helpful. RESULTS: Among 69 fellowship programs, only 39% (n = 27) participated in QOPI. Other findings were that (1) the majority of programs considered their fellows' QI projects beneficial but were not fulfilling the ACGME standard for all fellows' QI participation; (2) nonparticipating programs were unfamiliar with but interested in QOPI; (3) participating programs tended to view QI as easier to conduct and more beneficial than nonparticipating programs; and (4) programs that withdrew from QOPI and participating programs alike were dissatisfied with the educational benefit and data abstraction burden for fellows. CONCLUSION: Academic oncology programs generally valued QI but many have not fully engaged in it. Fellows in programs participating in QOPI may have had less difficulty conducting QI and their projects may have been more beneficial than that of nonparticipating programs. However, perceived lack of educational benefits for fellows and the burden of manual data abstraction from the electronic medical record are impediments to satisfaction with the program. Higher faculty involvement and longitudinal reports for each fellow may significantly increase participation.

Full Text

Duke Authors

Cited Authors

  • Makhoul, I; Anders, M; Siegel, R; Chiang, A; Markham, M-J; Chen, RC; Mougalian, S; Arnaoutakis, K; Giuliani, M; Im, A; Kozlik, MMP; Crist, STS; Garrett-Mayer, E; Kamal, A

Published Date

  • July 2022

Published In

  • Jco Oncol Pract

Volume / Issue

  • 18 / 7

Start / End Page

  • e1209 - e1218

PubMed ID

  • 35467961

Electronic International Standard Serial Number (EISSN)

  • 2688-1535

Digital Object Identifier (DOI)

  • 10.1200/OP.21.00807


  • eng

Conference Location

  • United States